The reactor with controlled feed rate and temperature allows rapid optimization of processing for your specific needs, and our engineering and sales team is always available to answer your questions.
Materials Research Centre (MRC) offers manufacturing of Etching Reactor for MXene synthesis.
MRC mission is technology development, design and manufacturing of specialized laboratory equipment for different research needs. Our staff includes engineers trained in design, manufacturing, as well as nanotechnology, chemistry, electrochemistry, and materials science. We can help you to develop solutions for your needs within a wide range of materials and equipment for their manufacturing.
ETCHING REACTOR FOR ACID ETCHING OF MAX-PHASE POWDERS, PRODUCTIVITY UP to 100 g / DAY
While most nanomaterials are only available in “nano” quantities, research team of professor Yury Gogotsi in Drexel Nanomaterials Institute, Drexel Universuty (USA) can make in their lab as much as 100 grams of MXene at a time, using a reactor developed with the Materials Research Center in Ukraine.
The reactor with controlled feed rate and temperature allows rapid optimization of processing for your specific needs, and our engineering and sales team is always available to answer your questions.
Operation of of Etching Reactor for MXene synthesis
Solution for MAX-phase for etching is poured into reactor and hermetically closed by a cover, which enables a controlled and safe removal of hydrogen.
MAX-phase feeding is done at a constant rate. To prevent deposition of material, the solution is constantly mixed. Chemical reaction of MAX-phase etching is exothermic. A water-cooled shell and feeder for material supply are designed for the temperature control.
MAX-phase etching is done following, for example, the reaction:
Ti3AlC2 + 3HF + 2H2O = AlF3 + 5/2H2 + Ti3C2(ОН)2
Hydrogen that is formed during the etching process flows into the discharge system for further utilization or is discharged. After etching, the solution is discharged for product purification from reaction products and other impurities.
MRC offers:
Technology development
Flexible engineering design
Customized manufacturing tailored to meet your needs
MRC encourage you to learn more about the exciting possibilities we can offer you, and we look forward to partnering with you to improve your material's synthesis and manufacturing.
For further information and detailes about ordering MAX-phase powders and Etching Reactor for MXene synthesis please contact us at Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript
Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.